ABSTRACT
The risk factors playing a role in the development of mesh tape complications can be broadly divided into three categories: mesh-related, patient-related and surgery-related factors. Surgical management with mesh removal has been described to provide acceptable outcomes. Endoscopic management is becoming increasingly popular and represents a feasible and effective option in managing bladder or urethral mesh extrusion. Onward referral to a mesh complications management centre in such instances is advisable. The aim of the management is to rule out a reversible cause for urgency such as urinary tract infection, mesh exposure, local hematoma formation or bladder outlet obstruction. The 2019 NICE guidelines on management of mesh complications recognised that although the removal of synthetic mesh may be the option of choice for some women experiencing mesh complications, the surgery itself is associated with considerable morbidity and therefore cannot be supported as a first-line treatment.
